国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
南京地区医保新增儿科药物利用分析及医保支付预测
Application Analysis and Medicare Payments Prediction of New Selected Pediatric Drugs of Medical Insurance in Nanjing City
  
DOI:
中文关键词:  儿科药物  DDDs  用药金额  医疗保险
英文关键词:Pediatric drug  Defined daily dose  Consumption amount  Medical insurance
基金项目:江苏省药学会-Shire生物药学科研基金项目(编号:S201602)
作者单位
房文通1 戴惠珍2  罗璨 1 1.南京医科大学第一附属医院 南京 2100292.江苏省医药情报研究所 
摘要点击次数: 1536
全文下载次数: 831
中文摘要:
      摘 要 目的:分析南京地区34家医院2014~2016年医保新增儿科药物的利用情况,探讨其使用现状及发展前景,并预测其医保支付金额。方法:2014~2016年南京地区医保新增儿科药物的用药数据来自江苏省医药情报研究所。药物利用情况以用药金额、用药频度(DDDs)、限定日费用(DDC)和排序比(B/A)表示。结果:2014~2016年南京地区医保新增儿科药物的利用情况呈增长趋势,说明这些药物越来越得到临床的认可,这也是这些品种纳入医保的原因之一。3年来用药金额和DDDs最高的均为营养药物。各医保新增儿科药物品种中,用药金额靠前的有小儿碳酸钙D3颗粒、小儿复方氨基酸19AA I注射液、健儿消食合剂等,DDDs排名靠前的有小儿碳酸钙D3颗粒、小儿对乙酰氨基酚溶液和小儿布洛芬混悬剂。所有品种连续3年DDC基本稳定。DDC值高的小儿复方氨基酸18AA I注射剂和小儿复方氨基酸19AA I注射剂,其B/A值低。纳入“新医保”后,若DDDs不变,预测医保支付金额为3 243.96万元。结论:2014~2016年南京地区医保新增儿科药物利用基本合理,纳入“新医保”后,不会对医保支付造成很大负担。
英文摘要:
      ABSTRACT Objective:To analyze the application of new selected pediatric drugs of medical insurance in Nanjing city from 2014 to 2016, and to predict its medicare payments. Methods:The consumption of new selected pediatric drugs and total antitumor drugs in 2014 2016 was obtained from Jiangsu medicine information institute. Drug utilization was expressed as consumption amount, DDDs, DDC and B/A value. Results: From 2014 to 2016, drug utilization of new selected pediatric drugs increased year by year. The top in consumption amount and DDDs was nutrient drugs. Calcium carbonate D3 granula, amino acid 19AA I injection and Jianerxiaoshi mistura were high at consumption amount, while calcium carbonate D3 granula, acetaminophen solution and ibuprofen suspensoid were high at DDDs. DDC of most drugs kept stable relatively. The DDC values of amino acid 19AA I injection and amino acid 18AA I injection, while their B/A values were low. If DDDs have not changed, the estimated medicare payment was 32.44 millions. Conclusion:The application of new selected pediatric drugs of medical insurance in Nanjing city was rational in 2014 2016. Their inclusion of “health insurance” will not give big burden on medical payment.
查看全文  查看/发表评论  下载PDF阅读器
关闭